MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-12-10
DOI
10.1002/jcb.26865
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathway
- (2017) Ke-feng Wu et al. EXPERIMENTAL CELL RESEARCH
- The role of exosomes and miRNAs in drug-resistance of cancer cells
- (2017) Duc-Hiep Bach et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
- (2017) Chongyuan Zhang et al. MEDICAL SCIENCE MONITOR
- Current status on microRNAs as biomarkers for ovarian cancer
- (2016) Kira Philipsen Prahm et al. APMIS
- SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
- (2016) Juliana Carvalho Santos et al. CANCER RESEARCH
- SOX9 drives WNT pathway activation in prostate cancer
- (2016) Fen Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9
- (2016) Zhihong Li et al. ONCOLOGY REPORTS
- MiRNAs-mediated cisplatin resistance in breast cancer
- (2016) Xiu Chen et al. TUMOR BIOLOGY
- Prediction of resistance to chemotherapy in ovarian cancer: a systematic review
- (2015) Katherine L Lloyd et al. BMC CANCER
- The emerging role of microRNAs in resistance to lung cancer treatments
- (2015) Lauren MacDonagh et al. CANCER TREATMENT REVIEWS
- SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling
- (2015) Hongwei Liu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer
- (2015) Ying Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
- (2015) Priya Samuel et al. Expert Review of Anticancer Therapy
- GAMUT: GPU accelerated microRNA analysis to uncover target genes through CUDA-miRanda
- (2014) Shuang Wang et al. BMC Medical Genomics
- Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness
- (2014) Giuseppina Raspaglio et al. GENE
- Mechanism of miRNA-mediated repression of mRNA translation
- (2013) Tamas Dalmay Essays in Biochemistry
- Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
- (2013) Elena S. Martens-Uzunova et al. EUROPEAN UROLOGY
- MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells
- (2013) S. B. Rani et al. NEURO-ONCOLOGY
- Interactive exploration of RNA22 microRNA target predictions
- (2012) Phillipe Loher et al. BIOINFORMATICS
- miRcode: a map of putative microRNA target sites in the long non-coding transcriptome
- (2012) Ashwini Jeggari et al. BIOINFORMATICS
- Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal Adenocarcinoma
- (2012) Janel L. Kopp et al. CANCER CELL
- miRNAs as mediators of drug resistance
- (2012) Sierk Haenisch et al. Epigenomics
- Regulation of Human Chondrocyte Function through Direct Inhibition of Cartilage Master Regulator SOX9 by MicroRNA-145 (miRNA-145)
- (2011) Aida Martinez-Sanchez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes
- (2011) Harsh Dweep et al. JOURNAL OF BIOMEDICAL INFORMATICS
- SOX9 Elevation in the Prostate Promotes Proliferation and Cooperates with PTEN Loss to Drive Tumor Formation
- (2010) M. K. Thomsen et al. CANCER RESEARCH
- miRNAs in human cancer
- (2010) Thalia A Farazi et al. JOURNAL OF PATHOLOGY
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
- (2009) David S. Miller et al. JOURNAL OF CLINICAL ONCOLOGY
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation